Quality Initiative in Rectal Cancer trial
| ISRCTN | ISRCTN78363167 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN78363167 |
| ClinicalTrials.gov (NCT) | NCT00182130 |
| Protocol serial number | MCT-50013 |
| Sponsor | Juravinski Cancer Centre (Canada) |
| Funder | Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-50013) |
- Submission date
- 18/11/2004
- Registration date
- 15/08/2005
- Last edited
- 29/11/2013
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Marko Simunovic
Scientific
Scientific
Juravinski Cancer Centre
699 Concession Street
Hamilton, ON
L8V 5C2
Canada
| Phone | +1 905 575 6365 |
|---|---|
| marko.simunovic@hrcc.on.ca |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study acronym | QIRC |
| Study objectives | To test if the quality initiative in rectal cancer strategy, which is designed to positively influence surgeon practice, can decrease hospital rates of permanent colostomy and local tumour recurrence for surgically treated rectal cancer patients. |
| Ethics approval(s) | Ethics approval received from the McMaster University Research Ethics Board on the 30th August 2001. |
| Health condition(s) or problem(s) studied | Rectal cancer |
| Intervention | Surgeons in the 8 hospitals allocated to the experimental arm will be exposed to the QIRC strategy. The strategy includes a workshop, operative demonstrations, use of opinion leaders, audit and feedback, and a post-operative questionnaire. Hospitals in the control arm represent the normal practice environment. Accrual closed effective on the 11th December, 2004 (we are now conducting patient follow up as per protocol; minimum 30 month follow up; study follow up will be completed June 30, 2007). |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Rate of permanent colostomy |
| Key secondary outcome measure(s) |
1. Bowel, bladder and sexual function |
| Completion date | 31/05/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 672 |
| Key inclusion criteria | Hospital criteria: An Ontario hospital with a procedure volume of 15 or more major rectal cancer resections per year for fiscal years 1996 to 1998. Patient criteria: 1. Persons of either sex, age groups 18 and above 2. Consecutive patients undergoing major rectal cancer surgery 3. Tumor located within 15 cm of anal verge by rigid sigmoidoscopy, or, at or below the level of the sacral promontory at the time of surgery |
| Key exclusion criteria | Does not comply with the above criteria. |
| Date of first enrolment | 01/05/2002 |
| Date of final enrolment | 31/05/2006 |
Locations
Countries of recruitment
- Canada
Study participating centre
Juravinski Cancer Centre
Hamilton, ON
L8V 5C2
Canada
L8V 5C2
Canada
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/12/2013 | Yes | No | |
| Results article | results | 01/12/2013 | Yes | No | |
| Protocol article | protocol | 15/02/2008 | Yes | No |